Avalon Global Asset Management’s Gilead Sciences GILD Stock Holding History

Avalon Global Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-100,000	Closed	-$7.08M	–	47
2018 Q2	$7.08M	Buy	100,000 +20,000	+25%	+$1.41M	2.57%	16
2018 Q1	$6.03M	Buy	+80,000	New	+$6.36M	2.08%	16
2017 Q4	–	Sell	-40,000	Closed	-$3.24M	–	45
2017 Q3	$3.24M	Sell	40,000 -10,000	-20%	-$765K	1.24%	30
2017 Q2	$3.54M	Sell	50,000 -40,000	-44%	-$2.66M	1.98%	25
2017 Q1	$6.11M	Buy	+90,000	New	+$6.33M	3.19%	12
2016 Q3	–	Sell	-20,000	Closed	-$1.67M	–	44
2016 Q2	$1.67M	Buy	+20,000	New	+$1.77M	0.96%	37
2015 Q4	–	Sell	-30,000	Closed	-$2.95M	–	42
2015 Q3	$2.95M	Buy	30,000 +20,000	+200%	+$2.22M	2.12%	19
2015 Q2	$1.17M	Buy	+10,000	New	+$1.09M	0.77%	39
2014 Q2	–	Sell	-10,000	Closed	-$709K	–	63
2014 Q1	$709K	Buy	+10,000	New	+$784K	0.47%	52

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Avalon Global Asset Management's GILD Position: Q4 2017 in Review

Avalon Global Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 30,000 shares — an estimated $2.43M sold.

Avalon Global Asset Management first reported a position in GILD in Q1 2014 and held it in 12 quarters. The position peaked at $4.79M in Q3 2014. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Avalon Global Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Avalon Global Asset Management sold 30,000 Gilead Sciences shares in Q4 2017, an estimated $2.43M.
Avalon Global Asset Management first reported a position in Gilead Sciences in Q1 2014 and held it in 12 quarters.
Avalon Global Asset Management's Gilead Sciences position peaked at $4.79M in Q3 2014.
1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Avalon Global Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.